Aciphex: Advanced Proton Pump Inhibitor for Effective GERD Management
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.80 | $48.16 (0%) | 🛒 Add to cart |
| 90 | $0.75 | $72.24 $67.08 (7%) | 🛒 Add to cart |
| 120 | $0.72 | $96.32 $86.00 (11%) | 🛒 Add to cart |
| 180 | $0.68 | $144.48 $122.98 (15%) | 🛒 Add to cart |
| 270 | $0.67 | $216.72 $179.74 (17%) | 🛒 Add to cart |
| 360 | $0.65
Best per pill | $288.96 $235.64 (18%) | 🛒 Add to cart |
Synonyms | |||
Aciphex (rabeprazole sodium) is a proton pump inhibitor (PPI) designed to provide long-lasting relief from gastroesophageal reflux disease (GERD) and associated conditions by significantly reducing gastric acid production. Clinically proven and widely prescribed, Aciphex offers a targeted mechanism of action that promotes esophageal healing and symptom resolution. Its delayed-release formulation ensures optimal bioavailability and consistent acid suppression, making it a trusted choice among healthcare professionals for managing acid-related disorders.
Features
- Active ingredient: Rabeprazole sodium
- Delayed-release tablet formulation
- Available in 20 mg strength
- Designed for once-daily dosing
- Acid-resistant enteric coating
- FDA-approved for multiple indications
- Demonstrated efficacy in clinical trials
- Compatible with long-term maintenance therapy
Benefits
- Provides rapid and sustained relief from heartburn and acid regurgitation
- Promotes healing of erosive esophagitis with proven efficacy
- Reduces the risk of GERD symptom recurrence with consistent use
- Enables improved quality of life through effective symptom management
- Supports mucosal healing in conditions like Zollinger-Ellison syndrome
- Offers convenient once-daily dosing for enhanced patient adherence
Common use
Aciphex is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), including the healing and maintenance of erosive esophagitis. It is also prescribed for the treatment of duodenal ulcers, pathological hypersecretory conditions including Zollinger-Ellison syndrome, and in combination with antibiotics for Helicobacter pylori eradication in patients with duodenal ulcer disease. Healthcare providers may also consider off-label uses based on individual patient presentation and clinical judgment.
Dosage and direction
The recommended adult dosage for most indications is 20 mg once daily. For GERD and erosive esophagitis healing, treatment typically continues for 4-8 weeks, though some patients may require longer duration. Maintenance therapy for healed erosive esophagitis is generally 20 mg once daily. For H. pylori eradication, Aciphex 20 mg is administered twice daily as part of combination therapy for 7 days. Tablets should be swallowed whole, without chewing or crushing, and may be taken with or without food. Morning administration is generally recommended for optimal effect.
Precautions
Patients should be advised that Aciphex may mask symptoms of gastric malignancy, and appropriate diagnostic evaluation should be conducted before initiating therapy. Long-term use (particularly beyond one year) may be associated with increased risk of fractures of the hip, wrist, and spine. Hypomagnesemia has been reported rarely with prolonged PPI use, requiring periodic monitoring. Patients should be monitored for potential vitamin B12 deficiency with long-term therapy. Use with caution in patients with hepatic impairment, as rabeprazole is extensively metabolized in the liver.
Contraindications
Aciphex is contraindicated in patients with known hypersensitivity to rabeprazole, substituted benzimidazoles, or any component of the formulation. Concomitant use with rilpivirine-containing products is contraindicated due to potential for decreased antiviral efficacy. The product should not be used in patients receiving atazanavir or nelfinavir, as proton pump inhibitors may reduce their absorption and effectiveness.
Possible side effect
Common adverse reactions (≥2%) include headache, diarrhea, nausea, vomiting, abdominal pain, flatulence, and constipation. Less frequently reported effects include dizziness, rash, dry mouth, insomnia, and malaise. Serious adverse reactions may include Clostridium difficile-associated diarrhea, acute interstitial nephritis, cutaneous and systemic lupus erythematosus, cyanocobalamin (vitamin B12) deficiency, hypomagnesemia, and fundic gland polyps. Patients should report any persistent or severe symptoms to their healthcare provider.
Drug interaction
Aciphex may alter the absorption of drugs whose bioavailability is pH-dependent, including ketoconazole, iron salts, erlotinib, dasatinib, nilotinib, and mycophenolate mofetil. It may increase exposure to digoxin and methotrexate. Concurrent use with warfarin may require increased monitoring of INR and prothrombin time. Rabeprazole may interfere with the antiplatelet activity of clopidogrel, though clinical significance remains uncertain. CYP2C19 inhibitors may increase rabeprazole exposure.
Missed dose
If a dose is missed, patients should take it as soon as they remember, unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not take a double dose to make up for a missed dose. Consistent daily administration is important for optimal therapeutic effect, particularly for maintenance therapy.
Overdose
Limited experience exists with Aciphex overdose. Reported doses up to 80 mg have been well-tolerated. Rabeprazole is not readily dialyzable. In case of suspected overdose, supportive care and monitoring of clinical status are recommended. Specific antidotes are not available. Treatment should be symptomatic and supportive, with particular attention to electrolyte balance and hydration status. Healthcare providers should contact a poison control center for current management recommendations.
Storage
Store at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep in the original container with the lid tightly closed to protect from moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Protect from light and excessive humidity.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Aciphex is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Patients should not initiate, discontinue, or change dosage without consulting their physician. Individual results may vary, and not all patients will experience the same benefits or side effects. The full prescribing information should be consulted before use.
Reviews
Clinical studies demonstrate that Aciphex provides effective symptom relief in 80-90% of GERD patients within the first week of treatment. Endoscopic healing rates of erosive esophagitis approach 90-95% after 8 weeks of therapy. Patients report significant improvement in quality of life measures, particularly regarding sleep disturbance and dietary freedom. Healthcare providers appreciate the consistent efficacy and favorable safety profile, though some note the importance of periodic monitoring for long-term users. The convenient dosing schedule is frequently cited as a factor supporting medication adherence.